Literature DB >> 28768424

Surgical salvage of recurrence after resection of colorectal liver metastases: incidence and outcomes.

Nuh N Rahbari1, Michael I D'Angelica1.   

Abstract

Surgical resection remains the primary curative treatment option for patients with colorectal liver metastases. While the majority of patients will develop tumor relapse within or outside of the liver after hepatic metastasectomy, a subset of these patients may be amenable to salvage surgical resection. However, outcomes for this approach are not well defined. In this article, we summarize the current evidence for the incidence, feasibility and outcomes of salvage resection for recurrence after initial resection of colorectal liver metastases.

Entities:  

Year:  2017        PMID: 28768424      PMCID: PMC6095401          DOI: 10.2217/hep-2017-0002

Source DB:  PubMed          Journal:  Hepat Oncol        ISSN: 2045-0923


  48 in total

1.  Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.

Authors:  Bernard Nordlinger; Halfdan Sorbye; Bengt Glimelius; Graeme J Poston; Peter M Schlag; Philippe Rougier; Wolf O Bechstein; John N Primrose; Euan T Walpole; Meg Finch-Jones; Daniel Jaeck; Darius Mirza; Rowan W Parks; Murielle Mauer; Erik Tanis; Eric Van Cutsem; Werner Scheithauer; Thomas Gruenberger
Journal:  Lancet Oncol       Date:  2013-10-11       Impact factor: 41.316

2.  Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population.

Authors:  S Manfredi; A M Bouvier; C Lepage; C Hatem; V Dancourt; J Faivre
Journal:  Br J Surg       Date:  2006-09       Impact factor: 6.939

3.  Liver resection remains a safe procedure after neoadjuvant chemotherapy including bevacizumab: a case-controlled study.

Authors:  Dietmar Tamandl; Birgit Gruenberger; Markus Klinger; Beata Herberger; Klaus Kaczirek; Edith Fleischmann; Thomas Gruenberger
Journal:  Ann Surg       Date:  2010-07       Impact factor: 12.969

4.  Positron Emission Tomography-Computed Tomography for Patients with Recurrent Colorectal Liver Metastases: Impact on Restaging and Treatment Planning.

Authors:  Luca Viganò; Egesta Lopci; Guido Costa; Marcello Rodari; Dario Poretti; Vittorio Pedicini; Luigi Solbiati; Arturo Chiti; Guido Torzilli
Journal:  Ann Surg Oncol       Date:  2016-11-02       Impact factor: 5.344

5.  Good candidates for a third liver resection of colorectal metastasis.

Authors:  Shintaro Yamazaki; Tadatoshi Takayama; Shunji Okada; Atsuko Iwama; Yutaka Midorikawa; Masamichi Moriguchi; Hisashi Nakayama; Tokio Higaki; Masahiko Sugutani
Journal:  World J Surg       Date:  2013-04       Impact factor: 3.352

6.  Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.

Authors:  Gunnar Folprecht; Thomas Gruenberger; Wolf O Bechstein; Hans-Rudolf Raab; Florian Lordick; Jörg T Hartmann; Hauke Lang; Andrea Frilling; Jan Stoehlmacher; Jürgen Weitz; Ralf Konopke; Christian Stroszczynski; Torsten Liersch; Detlev Ockert; Thomas Herrmann; Eray Goekkurt; Fabio Parisi; Claus-Henning Köhne
Journal:  Lancet Oncol       Date:  2009-11-26       Impact factor: 41.316

7.  Actual 10-year survival after resection of colorectal liver metastases defines cure.

Authors:  James S Tomlinson; William R Jarnagin; Ronald P DeMatteo; Yuman Fong; Peter Kornprat; Mithat Gonen; Nancy Kemeny; Murray F Brennan; Leslie H Blumgart; Michael D'Angelica
Journal:  J Clin Oncol       Date:  2007-10-10       Impact factor: 44.544

8.  Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: results from an international multi-institutional analysis.

Authors:  Mechteld C de Jong; Skye C Mayo; Carlo Pulitano; Serena Lanella; Dario Ribero; Jennifer Strub; Catherine Hubert; Jean-François Gigot; Richard D Schulick; Michael A Choti; Luca Aldrighetti; Gilles Mentha; Lorenzo Capussotti; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2009-10-01       Impact factor: 3.452

Review 9.  Colorectal cancer.

Authors:  Hermann Brenner; Matthias Kloor; Christian Peter Pox
Journal:  Lancet       Date:  2013-11-11       Impact factor: 79.321

10.  Colorectal cancer survival: An analysis of patients with metastatic disease synchronous and metachronous with the primary tumor.

Authors:  Rajiv Kumar; Timothy J Price; Carol Beeke; Kunal Jain; Gargi Patel; Rob Padbury; Graeme P Young; David Roder; Amanda Townsend; Sarwan Bishnoi; Christos S Karapetis
Journal:  Clin Colorectal Cancer       Date:  2013-11-13       Impact factor: 4.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.